Blood News and Research

RSS

Einstein-Montefiore researchers to present multiple findings at Alzheimer's Association International Conference

Investigators at Montefiore Health System and Albert Einstein College of Medicine of Yeshiva University will present multiple findings at the Alzheimer's Association International Conference, taking place July 18-23 in Washington, D.C. Research topics include risk factors for developing amnestic mild cognitive impairment (aMCI)—a condition characterized by memory problems, and is most often a precursor of Alzheimer's dementia.

16 Jul 2015

Kalorama's new report on global advanced patient monitoring market

According to Kalorama Information, the global advanced patient monitoring market is currently worth about $31.4 billion, inclusive of devices, peripherals, software, packaged services and other applications. The market has benefited from the demand to move to a more wireless and streamlined operation both within major health facilities and in the home treatment markets.

16 Jul 2015

New imaging technique could help with early detection of Alzheimer's disease

Various types of information can be ascertained by the way blood flows through the brain. When a region of the brain has been activated, blood flow increases and oxygenation rises. By observing variations in blood flow with the help of non-invasive imaging, it is possible to determine which regions are at work at a given point in time and how they work together.

16 Jul 2015

Iowa researchers gain important insight into sudden unexpected death in epilepsy

Sudden unexpected death in epilepsy (SUDEP) is becoming increasingly recognized as a very real and devastating problem in which impaired breathing is thought to play a critical role. Researchers believe breathing may be impaired during and after seizures, without the patient's knowledge.

16 Jul 2015

New drug DSM265 shows potential to cure, prevent malaria

Researchers at UT Southwestern Medical Center and in Australia have shown that a drug currently in testing shows potential to cure malaria in a single dose and offers promise as a preventive treatment as well.

16 Jul 2015

Researchers create clinical pathway to identify OSA in high-risk, hospitalized patients

Obstructive Sleep Apnea (OSA) remains under-recognized in hospitalized patients, despite being associated with cardiovascular complications and sudden death. A multi-disciplinary group of researchers and physicians at Thomas Jefferson University and Hospitals have created a clinical pathway, or screening process, to identify the disorder in higher-risk, hospitalized patients and recently published the results in the Journal of Clinical Sleep Medicine.

16 Jul 2015

CU research suggests safe, lower-cost way to treat upper gastrointestinal tract problems in children

Physicians at the University of Colorado School of Medicine on the Anschutz Medical Campus have published research that suggests a safe and lower-cost way to diagnose and treat problems in the upper gastrointestinal tract of children.

16 Jul 2015

New hand-held paper machine could be used for point-of-care detection of infectious diseases, cancer

In the U.S. and other industrialized nations, testing for infectious diseases and cancer often requires expensive equipment and highly trained specialists. In countries where resources are limited, performing the same diagnostics is far more challenging. To address this disparity, scientists are developing a portable, low-cost "paper machine" for point-of-care detection of infectious diseases, genetic conditions and cancer.

16 Jul 2015

Emory University immunologists identify long-lived antibody-producing cells in bone marrow

Immunologists from Emory University have identified a distinct set of long-lived antibody-producing cells in the human bone marrow that function as an immune archive.

16 Jul 2015

Magnetic nanoparticles may hold key to bringing immunotherapy into successful clinical use

In recent years, researchers have hotly pursued immunotherapy, a promising form of treatment that relies on harnessing and training the body's own immune system to better fight cancer and infection. Now, results of a study led by Johns Hopkins investigators suggests that a device composed of a magnetic column paired with custom-made magnetic nanoparticles may hold a key to bringing immunotherapy into widespread and successful clinical use.

16 Jul 2015

Americord Registry reports new policy for client reimbursement

Americord Registry, a private cord blood, cord tissue, and placenta tissue banking company, announced today that it is introducing a new policy for client reimbursement. Starting immediately, Americord will offer full reimbursements for cancellation fees that are often incurred by parents who sign up with other cord blood banks.

15 Jul 2015

Rubicon Genomics completes $2 million growth capital financing

Rubicon Genomics, Inc., a provider of innovative pre-analytical reagent kits to improve the performance of genomic analytical platforms and enable the use of liquid biopsies, today announced that it has completed a $2 million growth capital financing.

15 Jul 2015

Gene therapy provides life-long protection to photoreceptor cells in animal model of retinitis pigmentosa

A collaboration between scientists in the UK and the USA has shown that gene therapy can give life-long protection to the light-sensitive photoreceptor cells responsible for colour vision in a mouse model of the most common inherited eye disorder.

15 Jul 2015

Women with low levels of anti-stress hormone at increased risk of getting breast cancer

A new study from Lund University in Sweden shows that women with low levels of an anti-stress hormone have an increased risk of getting breast cancer. The study is the first of its kind on humans and confirms previous similar observations from animal experiments.

15 Jul 2015

New review article explains link between PTSD and increased cardiovascular disease risk

A growing number of patient studies show that people who suffered post-traumatic stress disorder (PTSD) are at a higher risk of developing cardiovascular diseases, including stroke and heart attack. A new review article in American Journal of Physiology—Regulatory, Integrative and Comparative Physiology examines the recent scientific literature to explain how the two are linked.

15 Jul 2015

Diabetes drug metformin can also treat portal hypertension

The diabetes drug metformin continues to expand beyond its treatment for type 2 diabetes. In addition to its potential use in treating age-related health problems, metformin can treat portal hypertension—high blood pressure in the liver resulting from cirrhosis, according to a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology.

15 Jul 2015

Wayne State researcher receives $1.9 million grant to improve EPCs-based cell therapy for vascular diseases

Chunying Li, Ph.D., assistant professor in the Wayne State University School of Medicine's Department of Biochemistry and Molecular Biology, has secured his first R01 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to study the role and mechanism of the chemokine receptor CXCR2 in regulating new blood vessel formation, the so-called angiogenesis.

15 Jul 2015

Study examines accuracy, cost-effectiveness of new cholesterol guidelines in identifying increased CVD risk

An examination of the 2013 guidelines for determining statin eligibility, compared to guidelines from 2004, indicates that they are associated with greater accuracy and efficiency in identifying increased risk of cardiovascular disease (CVD) events and presence of subclinical coronary artery disease, particularly in individuals at intermediate risk, according to a study in the July 14 issue of JAMA.

15 Jul 2015

IU researcher plays role in recent FDA approval of Neupogen drug to treat people exposed to radiation

An Indiana University Melvin and Bren Simon Cancer Center researcher played a role in the recent Food and Drug Administration approval of a drug to treat people exposed to potentially lethal doses of radiation.

15 Jul 2015

New drug patiromer could improve potassium levels of patients with diabetic kidney disease

Among patients with diabetic kidney disease and hyperkalemia (elevated potassium levels in the blood), a potentially life-threatening condition, those who received the new drug patiromer, twice daily for four weeks, had significant decreases in potassium levels which lasted through one year, according to a study in the July 14 issue of JAMA.

15 Jul 2015

Blood News and Research

Einstein-Montefiore researchers to present multiple findings at Alzheimer's Association International Conference

Kalorama's new report on global advanced patient monitoring market

New imaging technique could help with early detection of Alzheimer's disease

Iowa researchers gain important insight into sudden unexpected death in epilepsy

New drug DSM265 shows potential to cure, prevent malaria

Researchers create clinical pathway to identify OSA in high-risk, hospitalized patients

CU research suggests safe, lower-cost way to treat upper gastrointestinal tract problems in children

New hand-held paper machine could be used for point-of-care detection of infectious diseases, cancer

Emory University immunologists identify long-lived antibody-producing cells in bone marrow

Magnetic nanoparticles may hold key to bringing immunotherapy into successful clinical use

Americord Registry reports new policy for client reimbursement

Rubicon Genomics completes $2 million growth capital financing

Gene therapy provides life-long protection to photoreceptor cells in animal model of retinitis pigmentosa

Women with low levels of anti-stress hormone at increased risk of getting breast cancer

New review article explains link between PTSD and increased cardiovascular disease risk

Diabetes drug metformin can also treat portal hypertension

Wayne State researcher receives $1.9 million grant to improve EPCs-based cell therapy for vascular diseases

Study examines accuracy, cost-effectiveness of new cholesterol guidelines in identifying increased CVD risk

IU researcher plays role in recent FDA approval of Neupogen drug to treat people exposed to radiation

New drug patiromer could improve potassium levels of patients with diabetic kidney disease

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News